Quackbase!
A database that tracks dubious medical claims.
Claimant: Solal Technologies
Type: Retailing Company
Website: http://www.solaltech.com/indexs.php
Claims and Responses
- Claim no 1: Solal Technologies Prevents Aging made on 2010-10-01 - Untested and implausible
Solal claims to be an "anti-aging specialist". This is one of their most strident claims.
- Response no 1: Treatment Action Campaign Complaint to ASASA on 2010-10-15
- Response no 3: ASASA Ruling on 2010-12-15
This is not a ruling on the complaint itself. Solal made contentions against Marcus Low, the complainant. ASASA dismissed these contentions and gave ASASA a final opportunity to respond to Low.
- Response no 68: ASASA Ruling on 2011-06-29
ASASA orders the Solal claims to be withdrawn. The complaint is only partially upheld because of a technical issue around Appendix A of the code.
- Claim no 2: Solal Technologies Improves Nutrition made on 2009-10-01 - Untested and implausible
Solal placed a health shake advertisement in Beeld.
- Response no 2: Harris Steinman Complaint to ASASA on 2009-10-09
- Response no 4: ASASA Ruling on 2009-12-02
Solal claims the advert was placed in error and so ASASA declines to investigate further.
- Claim no 25: Solal Technologies Delays macular degeneration made on 2010-05-01 - Untested and implausible
Solal claims in an advert in Fair Lady that their product delays macular degeneration. Their advert was also misleading about the causes of this condition.
- Response no 47: Dr. JC Laithwaithe Complaint to ASASA on 2010-08-01
- Response no 48: ASASA Ruling on 2010-08-30
ASASA upholds the complaint and rules that the Solal claim is unsubstantiated and must be withdrawn.
- Response no 81: ASASA Ruling on 2012-01-24
After reviewing a number of 'experts' presented by the respondent, claims remained unsubstantiated and the previous ruling was upheld
- Response no 87: ASASA ASA Directorate Ruling on 2012-04-17
The ASA Directorate ruled that Solal's current advertising and packaging are in breach of the original ruling, and therefore in breach of Clause 15 of the Procedural Guide.
- Claim no 26: Solal Technologies Alleviates Vitamin Deficiency made on 2011-02-01 - Tests are disputed or inconclusive
This Solal flyer claimed that more than 80% of South Africans tested are deficient in vitamin D3, which is essential for heart health.
- Response no 46: Kevin Charleston Complaint to ASASA on 2011-02-02
- Response no 49: ASASA Ruling on 2011-02-18
ASASA rules in favour of complainant, Kevin Charleston, and orders the advert to be withdrawn because it is in contravention of Appendix F.
- Claim no 31: Solal Technologies Sugar has harmful effects made on 2009-12-01 - Hyperbole
A Solal advert in the Star claims that too much sugar or artificial sweetners can cause cancer. This sets off a protracted battle at ASASA with the Sugar Association.
- Response no 55: South African Sugar Association Complaint to ASASA on 2009-11-01
- Response no 56: ASASA Ruling on 2009-12-01
The Solal claims are not substantiated. The complaint was upheld and the claims ordered to be withdrawn.
- Response no 57: Solal Technologies Appeal to ASASA on 2010-02-22
- Response no 59: ASASA Ruling on 2010-05-17
Solal presents an expert witness who verifies their claims. ASASA rules in Solal's favour.
- Response no 64: ASASA Ruling on 2011-05-05
Solal ordered to withdraw advert that makes hyperbolic claims about the ill-effects of sugar
- Response no 69: ASASA Ruling on 2011-06-30
ASASA dismisses a complaint by the Sugar Association that Solal was in breach of a ruling by ASASA of 5 May 2011. The ruling has implications for adverts stored in Google cache.
- Response no 74: ASASA Ruling on 2011-09-06
Solal Technologies' application for the suspension of ASASA's ruling (05/05/2011) was denied
- Response no 76: ASASA Ruling on 2011-09-20
Solal again appealed the ASA decision in favour of the Sugar Association. The ASA has ruled against Solal's new appeal.
- Claim no 32: Solal Technologies Vitamin D functions as a vaccine made on 2010-08-26 - Untested and implausible
Solal placed an advert in The Star claiming that Vitamin D is as effective as a vaccine.
- Response no 60: Kevin Charleston Complaint to ASASA on 2010-07-26
- Response no 61: ASASA Ruling on 2010-08-26
ASASA rules in favour of complainant Kevin Charleston. The claim that Vitamin D is as effective as a vaccine is unsubstantiated and must be withdrawn.
- Response no 84: ASASA Ruling on 2012-02-14
Solal submitted new evidence to support its claim that Vitamin D is an effective vaccine. The substantiation was rejected by ASASA and the August 2010 ruling was therefore upheld.
- Claim no 33: Solal Technologies Improves Nutrition made on 2009-09-05 - Untested
Solal ran an advert titled "Why Solal Technologies believes that omega 3s from krill oil are better than fish oil."
- Response no 62: Vital Health Foods Complaint to ASASA on 2009-11-01
- Response no 63: ASASA Ruling on 2009-11-23
ASASA upholds a competitor complaint against Solal. Solal's claims are unsubstantiated and must be withdrawn.
- Claim no 35: Solal Technologies Cures Hangovers made on 2011-04-10 - Untested
Solal ran an advert in the Cape Times claiming that their products are a quick fix for hangovers
- Claim no 43: Solal Technologies Helps Stop Smoking made on 2011-06-15 - Untested and implausible
This advert claims that several products can prevent heart disease or help you give up smoking and reduce the risk of a heart attack.
- Claim no 45: Solal Technologies Prevents Heart Disease made on 2010-10-01 - Untested
Solal claims Omega 3 deficiency can increase the risk of heart attacks, strokes, arthritis, diabetes and depression and that most people are deficient in Omega 3.
- Response no 70: ASASA Ruling on 2011-06-29
ASASA rules in favour of complainant, Kevin Charleston, and orders the advert to be withdrawn because it is in contravention of Appendix F.
- Response no 70: ASASA Ruling on 2011-06-29
- Claim no 58: Solal Technologies Increases risk of heart attack, diabetes, depression and arthritis Omega deficiency made on 2010-10-04 - Untested and implausible
Solal Technologies made unsubstantiated claims that omega deficiency increases the risk of numerous diseases
- Response no 77: ASASA Ruling on 2011-10-07
ASASA dismissed Solal's appeal
- Response no 83: ASASA Ruling on 2012-02-02
Final Appeals Committee of ASA overturned earlier ruling that Solal advert violated appendix F.
- Response no 77: ASASA Ruling on 2011-10-07
- Claim no 61: Solal Technologies Protects Heart Disease made on 2012-02-14 - Tests are disputed or inconclusive
The advert suggests the product protects the heart and brain from stress damage
- Response no 86: ASASA ASA Directorate Ruling on 2012-03-22
ASASA rules that claims in a Solal “Stress at work increases the risk of heart attack by 300-600%" advertisement are unsubstantiated.
- Response no 86: ASASA ASA Directorate Ruling on 2012-03-22
- Claim no 66: Solal Technologies Reduces Aging made on 2011-03-01 - Untested and implausible
The advert claims that the supplements will reduce aging, provide all of the nutrients needed
- Response no 90: ASASA ASA Directorate Ruling on 2011-06-29
The ASA ruled that the statement "Prescribed by Doctors, Recommended by Pharmacists" was unstbstantiated and should not be used.
- Response no 91: ASASA ASA Directorate Ruling on 2012-04-03
Solal submitted further substantiation, and the ASA reversed their earlier decision.
- Response no 90: ASASA ASA Directorate Ruling on 2011-06-29